NCT06952127 (TEPCO) is a NA clinical trial of Rehabilitation program in Long COVID-19 Syndrome, sponsored by Centre intégré universitaire de santé et de services sociaux de la Mauricie-et-du-Centre-du-Québec.

What drugs are being tested in NCT06952127?

Interventions in NCT06952127: Rehabilitation program.

What condition does NCT06952127 study?

NCT06952127 studies Long COVID-19 Syndrome, Long COVID, Long COVID Syndrome.

Is NCT06952127 still recruiting?

NCT06952127 is currently completed. Last updated 30 April 2025.

Last reviewed 2025-04-30 · How we verify

NCT06952127: TEPCO

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Feasibility and Preliminary Efficacy of a Group-based Telerehabilitation Program in People With Post-COVID-19 Sequelae (TEPCO).

Completed NA Last updated 30 April 2025

What this trial tests

NA trial testing Rehabilitation program in Long COVID-19 Syndrome in 22 participants. Completed in 29 March 2024.

Timeline

7 April 2023

Primary endpoint
29 March 2024

29 March 2024

Quick facts

Lead sponsor	Centre intégré universitaire de santé et de services sociaux de la Mauricie-et-du-Centre-du-Québec
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	22
Start date	7 April 2023
Primary completion	29 March 2024
Estimated completion	29 March 2024
Sites	1 location across Canada

Drugs / interventions tested

Rehabilitation program

Conditions studied

Long COVID-19 Syndrome — all drugs for Long COVID-19 Syndrome →
Long COVID — all drugs for Long COVID →
Long COVID Syndrome — all drugs for Long COVID Syndrome →

Sponsor

Centre intégré universitaire de santé et de services sociaux de la Mauricie-et-du-Centre-du-Québec

Who can join

18 and older, any sex, with Long COVID-19 Syndrome or Long COVID. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this study pilot randomized controlled study is to evaluate the feasibility of the study procedures and to compare the preliminary efficacy of a rehabilitation program given in a "remote" (telerehabilitation) or "face-to-face" model for adult patients who had confirmed SARS-CoV-2 infection and still have symptoms after eight weeks of infection. The main question it aims to answer is: * Are the study procedures feasible? * Will the two groups have similar results for the preliminary efficacy outcomes? Researchers will compare group telerehabilitation to a face-to-face group to see if it's comparable. Participants will: * Take part in a 60-minute training session, 3 times a week in person or remotely * Visit the clinic before starting the training program and after 8 weeks of training * Keep a diary of their symptoms, if any

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Rehabilitation program

Trials testing the same drug.

NCT07433972 — Changes in Hemodynamic Response Following Transcranial Electrical Stimulation in Sroke Individuals · NA · not yet recruiting
NCT07205627 — Evaluation of the Diaphragmatic Index Before and After a Pulmonary Rehabilitation Program in Patients With Interstitial · NA · not yet recruiting
NCT05848518 — Exercise for Health in Patients With Post-acute Sequelae of COVID-19 · NA · completed
NCT04031079 — Use of Wearable Tech to Increase Physical Activity in Inpatient Rehabilitation for Overweight and Obese Patients · NA · completed
NCT04031092 — Use of Wearable Tech to Increase Physical Activity in Inpatient Rehabilitation for Patients With Chronic Pain · NA · completed

Other recruiting trials for Long COVID-19 Syndrome

Currently open trials in the same condition.

NCT07316127 — Immunoadsorption in Autoimmune Long COVID · Phase 2 · recruiting
NCT07110714 — Effects of Kneipp Hydrotherapy in Post-COVID-19 Patients · NA · recruiting
NCT06871293 — Evaluating the Impact of a Functional and Cognitive Strategy in Patients With Long Covid-19 · NA · recruiting
NCT06940609 — Magnetic Resonance Analysis of Neural Inflammatory Factors and External Stimulation · Phase 2 · recruiting
NCT07046442 — Effect of Pulmonary Rehabilitation and Physical Activity on Long COVID (PuReCOVID) · active not recruiting

Other Centre intégré universitaire de santé et de services sociaux de la Mauricie-et-du-Centre-du-Québec trials

Trials by the same sponsor.

NCT07089030 — Endoscopic Evaluation for Iron Deficiency Anemia in Patients on Antithrombotic Therapy · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06952127 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Centre intégré universitaire de santé et de services sociaux de la Mauricie-et-du-Centre-du-Québec
Last refreshed: 30 April 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06952127.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing